BGT — Bio-Gene Technology Balance Sheet

0.000.00%

Last trade - 00:00

Basic MaterialsSpeculativeMicro CapSucker Stock

Annual balance sheet for Bio-Gene Technology, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th	2026 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	AAS	AAS	AAS	AAS	AAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	6.34	2.99	2.21	1.14	1.94
Net Total Accounts Receivable
Net Total Receivables	0.438	0.446	0.524	0.472	0.408
Prepaid Expenses
Total Other Current Assets
Total Current Assets	7	3.58	2.94	1.97	2.47
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.023	0.015	0.019	0.013	0.008
Net Intangible Assets
Total Assets	7.3	3.84	3.16	2.15	2.61
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1.01	0.574	0.346	0.51	0.517
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1.03	0.614	0.368	0.523	0.52
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	6.27	3.22	2.79	1.63	2.09
Total Liabilities & Shareholders' Equity	7.3	3.84	3.16	2.15	2.61
Total Common Shares Outstanding